ChemicalBook > Product Catalog >Biochemical Engineering >Polypeptide >Lixisenatide

Lixisenatide

Lixisenatide Structure
CAS No.
320367-13-3
Chemical Name:
Lixisenatide
Synonyms
Lyxumia;lixisenatide;Lixisenatide, >98%;Lixisenatide Acetate;Lixisenatide USP/EP/BP;Lixisenatide|Lixisenatide Acetate
CBNumber:
CB01518519
Molecular Formula:
C215H347N61O65S
Molecular Weight:
4858.53
MOL File:
320367-13-3.mol
MSDS File:
SDS
Modify Date:
2024/7/2 8:54:57

Lixisenatide Properties

storage temp. Store at -20°C
solubility Water:103.0(Max Conc. mg/mL);21.2(Max Conc. mM)
form Solid
color White to pink
Sequence H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2
InChIKey XVVOERDUTLJJHN-JXBMKTOPNA-N
CAS DataBase Reference 320367-13-3

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS08,GHS05
Signal word  Danger
Hazard statements  H318-H361
Precautionary statements  P201-P202-P281-P308+P313-P405-P501-P280-P305+P351+P338-P310

Lixisenatide Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 137)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Wuhan Fortuna Chemical Co., Ltd +86-027-59207850 China 5999 58 Inquiry
Apextide Co Ltd +86-15300650552 +86-15300650552 China 71 58 Inquiry
Zibo Hangyu Biotechnology Development Co., Ltd +86-0533-2185556 +8617865335152 China 11027 58 Inquiry
Nantong Guangyuan Chemicl Co,Ltd +undefined17712220823 China 616 58 Inquiry
Shanghai Getian Industrial Co., LTD +86-15373193816 +86-15373193816 China 274 58 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32760 60 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29901 58 Inquiry
Shenzhen Nexconn Pharmatechs Ltd +86-755-89396905 +86-15013857715 China 10259 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19553 58 Inquiry

Related articles

  • Application of Lixisenatide
  • Lixisenatide (Adlyxin, Sanofi-Aventis) is the newest FDA-approved GLP-1RA and obtained approval on July 27, 2016.
  • Dec 13,2021
lixisenatide Lixisenatide|Lixisenatide Acetate Lixisenatide Acetate Lixisenatide, >98% Lixisenatide USP/EP/BP Lyxumia 320367-13-3 C215H347N61O65S